Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
Apyx Medical (NASDAQ:APYX), the manufacturer of Renuvion®, a proprietary helium plasma and radiofrequency platform technology, has announced that it will release its second quarter fiscal year 2024 financial results on August 8, 2024, after market close. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results and conduct a Q&A session.
Interested parties can dial 888-645-4404 (or 862-298-0702 for international callers) with access code 13747529 to join the call. A live webcast will also be available via the company's Investor Relations website. A telephonic replay will be accessible for two weeks following the call.
Apyx Medical (NASDAQ:APYX), il produttore di Renuvion®, una tecnologia proprietaria basata su plasma di elio e radiofrequenza, ha annunciato che pubblicherà i suoi risultati finanziari del secondo trimestre dell'anno fiscale 2024 il 8 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 17:00 ora orientale nello stesso giorno per discutere i risultati e condurre una sessione di domande e risposte.
Le parti interessate possono chiamare il 888-645-4404 (o 862-298-0702 per chiamate internazionali) con il codice di accesso 13747529 per partecipare alla chiamata. Sarà disponibile anche una diretta streaming sul sito web delle Relazioni con gli Investitori dell'azienda. Una registrazione telefonica sarà accessibile per due settimane dopo la chiamata.
Apyx Medical (NASDAQ:APYX), el fabricante de Renuvion®, una tecnología de plataforma de plasma de helio y radiofrecuencia, ha anunciado que publicará sus resultados financieros del segundo trimestre del año fiscal 2024 el 8 de agosto de 2024, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica a las 5:00 p.m. hora del este el mismo día para discutir los resultados y realizar una sesión de preguntas y respuestas.
Las partes interesadas pueden marcar el 888-645-4404 (o 862-298-0702 para llamadas internacionales) con el código de acceso 13747529 para unirse a la llamada. También estará disponible una transmisión en vivo a través del sitio web de Relaciones con Inversores de la empresa. Se podrá acceder a una grabación telefónica durante dos semanas después de la llamada.
Apyx Medical (NASDAQ:APYX)는 헬륨 플라즈마 및 라디오 주파수 플랫폼 기술인 Renuvion®의 제조업체로서 2024 회계연도 2분기 재무 결과를 2024년 8월 8일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 5시 동부 표준시에 결과를 논의하고 질의응답 세션을 진행하기 위해 전화 회의를 주최합니다.
관심 있는 당사자는 888-645-4404 (국제 전화의 경우 862-298-0702)로 전화하여 액세스 코 13747529를 입력하여 통화에 참여할 수 있습니다. 회사의 투자자 관계 웹사이트를 통해 생중계도 제공될 예정입니다. 통화 후 2주간 전화 재생도 이용할 수 있습니다.
Apyx Medical (NASDAQ:APYX), le fabricant de Renuvion®, une technologie de plateforme à base de plasma d'hélium et de radiofréquence, a annoncé qu'il publiera ses résultats financiers du deuxième trimestre de l'exercice 2024 le 8 août 2024, après la fermeture du marché. La société organisera une conférence téléphonique à 17h00 heure de l'Est le même jour pour discuter des résultats et mener une session de questions-réponses.
Les parties intéressées peuvent composer le 888-645-4404 (ou 862-298-0702 pour les appelants internationaux) avec le code d'accès 13747529 pour participer à l'appel. Un webinaire en direct sera également disponible via le site web des Relations Investisseurs de l'entreprise. Un enregistrement téléphonique sera accessible pendant deux semaines après l'appel.
Apyx Medical (NASDAQ:APYX), der Hersteller von Renuvion®, einer proprietären Helium-Plasma- und Radiofrequenzplattformtechnologie, hat bekannt gegeben, dass die finanziellen Ergebnisse des zweiten Quartals des Geschäftsjahres 2024 am 8. August 2024 nach Marktschluss veröffentlicht werden. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen und eine Fragerunde durchzuführen.
Interessierte können die Nummer 888-645-4404 (oder 862-298-0702 für internationale Anrufer) mit dem Zugangscode 13747529 anrufen, um an der Konferenz teilzunehmen. Ein Live-Webcast wird ebenfalls über die Investor-Relations-Website des Unternehmens verfügbar sein. Eine telefonische Aufzeichnung wird zwei Wochen nach der Konferenz zugänglich sein.
- None.
- None.
Management will host a conference call at 5:00 p.m. Eastern Time on August 8th to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 888-645-4404 (or 862-298-0702 for international callers) and provide access code 13747529. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company’s website and via the following link: Apyx Medical Earnings Webcast
A telephonic replay will be available approximately three hours after the call ends through the following two weeks. The replay can be accessed by dialing 877-660-6853 for
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240725161107/en/
Investor Relations:
ICR Westwicke on behalf of Apyx Medical Corporation
Mike Piccinino, CFA
investor.relations@apyxmedical.com
Source: Apyx Medical Corporation
FAQ
When will Apyx Medical (APYX) release its Q2 2024 financial results?
How can investors join Apyx Medical's (APYX) Q2 2024 earnings call?
What time is Apyx Medical's (APYX) Q2 2024 earnings conference call scheduled?
What is Apyx Medical 's (APYX) main product?
